Source comparison
BPC-157 Research DEXA Scan Notes: Study Design Comparison
Injured athletes (n=18) 250mcg 2x daily × 12 weeks Baseline, Week 6, Week 12 +1.2kg vs −1.8kg control +2.1% regional BMD Lean mass preservation exceeds standard rehab protocols—strongest effect in injury-adjacent tissue Hindlimb suspension rats (n=24) 10mcg/kg
This comparison does not assign a generated winner or score.
- Injured athletes (n=18)
- 250mcg 2x daily × 12 weeks
- Baseline, Week 6, Week 12
- +1.2kg vs −1.8kg control
- +2.1% regional BMD
- Lean mass preservation exceeds standard rehab protocols—strongest effect in injury-adjacent tissue
- Hindlimb suspension rats (n=24)
- 10mcg/kg daily × 14 days
- Day 0, Day 7, Day 14
- 89% baseline vs 64% control
- No significant change
- Confirms anti-atrophy mechanism independent of mechanical load—effect size scales with dose
- Tendon repair patients (n=12)
- 500mcg 2x daily × 8 weeks
- Baseline, Week 4, Week 8, Week 16 post
- +1.8kg, 80% retained at Week 16
- +3.4% peri-injury site
- Highest documented lean mass gain—suggests 500mcg 2x daily may be optimal for soft tissue injury models
- Aging subjects (n=30)
- 250mcg daily × 16 weeks
- Baseline, Week 8, Week 16
- +0.6kg total, +1.1kg leg mass
- +1.8% lumbar spine
- Modest systemic effect—stronger regional response in loaded muscle groups